Pathstone Holdings’s CollPlant Biotechnologies CLGN Stock Holding History

Pathstone Holdings’s Portfolio CLGN Stock Details CLGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$30.6K	Buy	57,000 +40,000	+235%	+$40.4K	﹤0.01%	2200
2025 Q4	$23.8K	Hold	17,000	–	–	﹤0.01%	2208
2025 Q3	$45.7K	Sell	17,000 -17,000	-50%	-$40.5K	﹤0.01%	2310
2025 Q2	$23.1K	Buy	34,000 +17,000	+100%	+$35.2K	﹤0.01%	2166
2025 Q1	$43.9K	Hold	17,000	–	–	﹤0.01%	2182
2024 Q4	$61.2K	Hold	17,000	–	–	﹤0.01%	2256
2024 Q3	$84.4K	Buy	+17,000	New	+$83.2K	﹤0.01%	2252

Other funds holding CLGN

SDJVC

St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

LWMI

Legacy Wealth Management (Idaho) Boise, Idaho $201M AUM 259.85% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

WPC

Waters Parkerson & Co New Orleans, Louisiana $1.95B AUM 15.9% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Pathstone Holdings's CLGN Position: Q1 2026 in Review

Pathstone Holdings increased its CollPlant Biotechnologies (CLGN) stake by 235% in Q1 2026, buying an estimated $40.4K and bringing the position to 57,000 shares worth $30.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2200.

Pathstone Holdings first reported a position in CLGN in Q3 2024 and has held it in 7 quarters since. The position peaked at $84.4K in Q3 2024. 21 funds tracked by Wall St. Rank hold CLGN as of Q1 2026.

Pathstone Holdings held 57,000 shares of CollPlant Biotechnologies worth $30.6K as of Q1 2026.
Pathstone Holdings bought 40,000 CollPlant Biotechnologies shares in Q1 2026, an estimated $40.4K.
CollPlant Biotechnologies made up ﹤0.01% of Pathstone Holdings's portfolio in Q1 2026, its #2200 holding.
Pathstone Holdings first reported a position in CollPlant Biotechnologies in Q3 2024 and has held it in 7 quarters since.
Pathstone Holdings's CollPlant Biotechnologies position peaked at $84.4K in Q3 2024.
21 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q1 2026.

Based on Pathstone Holdings's 13F filing for Q1 2026, filed 11 May 2026.